Falcon Point Capital’s Abiomed Inc ABMD Stock Holding History

Falcon Point Capital’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-85,726	Closed	-$9.37M	–	115
2016 Q2	$9.37M	Sell	85,726 -6,733	-7%	-$670K	1.62%	32
2016 Q1	$8.77M	Buy	92,459 +23,189	+33%	+$1.96M	1.51%	34
2015 Q4	$6.25M	Buy	69,270 +47,070	+212%	+$3.99M	1.35%	39
2015 Q3	$2.06M	Sell	22,200 -29,379	-57%	-$2.59M	0.74%	48
2015 Q2	$3.39M	Buy	51,579 +25,656	+99%	+$1.7M	1.15%	38
2015 Q1	$1.86M	Sell	25,923 -21,932	-46%	-$1.19M	1.44%	21
2014 Q4	$1.82M	Sell	47,855 -19,560	-29%	-$617K	1.67%	15
2014 Q3	$1.67M	Buy	67,415 +51,394	+321%	+$1.3M	1.41%	21
2014 Q2	$403K	Buy	+16,021	New	+$373K	0.41%	90

Other funds holding ABMD

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Falcon Point Capital's ABMD Position: Q3 2016 in Review

Falcon Point Capital sold out of Abiomed Inc (ABMD) in Q3 2016, closing a stake of 85,726 shares — an estimated $9.37M sold.

Falcon Point Capital first reported a position in ABMD in Q2 2014 and held it in 9 quarters. The position peaked at $9.37M in Q2 2016. 305 funds tracked by Wall St. Rank hold ABMD as of Q3 2016.

Falcon Point Capital reported no remaining Abiomed Inc position as of Q3 2016 after selling out during the quarter.
Falcon Point Capital sold 85,726 Abiomed Inc shares in Q3 2016, an estimated $9.37M.
Falcon Point Capital first reported a position in Abiomed Inc in Q2 2014 and held it in 9 quarters.
Falcon Point Capital's Abiomed Inc position peaked at $9.37M in Q2 2016.
305 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2016.

Based on Falcon Point Capital's 13F filing for Q3 2016, filed 8 Nov 2016.